Three Cell And Gene Therapies Reach Critical Review Stage In EU

BMS, bluebird bio And PTC Therapeutics Need To Address Reviewers' Outstanding Issues

 
• By Maureen Kenny
  
The EU is evaluating a number of novel advanced therapies • Source: Alamy

More from Europe

More from Geography